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Assessment of morphology and distribution of capillaries in 
patients with SSc and healthy individuals in nailfold capillaroscopy
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ABSTRACT
Introduction: Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular damage and immunological abnormali-
ties leading to fibrosis that can damage multiple organs. The pathogenesis is complex and still poorly understood. However impaired 
angiogenesis in SSc has a major role in tissue injury and sequelae fibrosis.
Nailfold capillaroscopy (NC)/nailfold videocapillaroscopy (NVC) is safe and non-invasive methods used to investigate microvascular 
changes in the peripheral circulation and it is a method of great diagnostic value in diagnosing and monitoring the patients with SSc. 
Typical microvascular alterations, called scleroderma pattern characterized by giant capillaries, haemorrhages and successive loss of 
capillaries, are observed at NC/NVC in a significant percentage of SSc patients, hence our interest was focused on the assessment of NVC 
in patient with systemic sclerosis (SSc).
Material and methods: Thirty patients with SSc according to the ACR and EULAR criteria and healthy volunteers underwent NVC assessment. 
Nailfold capillaroscopy was performed by a videocapillaroscope and the picture of the capillaries at the hands were documented and evaluate.
Results: NVC disturbed patterns were significantly prominent in SSc patients (p < 0.05) compared to the healthy control group. A normal 
capillaroscopic pattern was not observed in patients with SSc. The number of loops/mm was significantly lower in SSc group (p < 0.05) and 
was 4.28 capillaries/mm (min.1/mm; max. 10/mm). We did not notice significant difference in frequency of mega-capillaries (lcSSc/dcSSc: 
41%/29%, p > 0.05) and avascular areas (lcSSc/dcSSc: 64%/57%, p > 0.05) between limited (lSSc) and diffuse (dSSc) SSc.
Conclusions: Severe capillary damage is characteristic for SSc patients therefore NVC seems to be useful for selection of patients de-
veloping SSc.
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INTRODUCTION
Systemic sclerosis (scleroderma — SSc) is a chronic au-
toimmune disease of the connective tissue, characterized 
by immunological disorders, including general microan-
giopathy and progressive fibrosis. Now, it is believed that 
vascular disorders — apart from characteristic skin fibrosis 
— are a dominant SSc feature. In 1988, LeRoy [1] pointed 
out the need to broaden the criteria of SSc diagnosis, es-
tablished by American College of Rheumatology [2], by, 
among others, disorders found in capillaroscopic examina-
tion. In 2001, LeRoy and Medsger expanded the diagnostic 
major criteria by Raynaud phenomenon [3]. Minor criteria 
included changes in capillaroscopic image and antibodies 
characteristic for SSc, which enabled an early diagnosis of 
SSc. Subsequently, EULAR/EUSTAR (European League against 
Rheumatism/ EULAR Scleroderma Trials and Research group) 
[4] focused on patients who did not meet all criteria due to 
an early stage of the disease but in whom early diagnosis 
and medical care were indicated. This group of patients was 
named pre-scleroderma.
Capillaroscopy has become a basic, non-invasive addi-
tional examination in diagnosis of SSc and other connective 
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Figure 1. Normal capillaroscopic image with U-shaped capillaries
Figure 2. „Active” capillaroscopic scleroderma pattern according to 
Cutolo with giant capillaries, haemorrages, moderate capillary loss 
and mild disorganisation
Figure 3. „Late” capillaroscopic scleroderma pattern according to 
Cutolo with irregular enlargment of capillaries and severe capillaries 
loss with disorganisation
and prognosis of future development of rheumatic dise-
ases. NVC is mostly used in SSc diagnosis and observation 
as capillaroscopic changes are observed in over 90% of 
patients [5, 6] (Fig.1, 2, 3).
The aim of the study was to assess capillaroscopic chan-
ges in the investigated group of patients with SSc.
MATERIAL AND METHODS
The study was carried out on 30 patients with SSc (7 pa-
tients with dSSc and 23 with lSSc) and 15 healthy volun-
teers. All patients fulfilled SSc criteria according to ACR and 
EULAR (2013) [2, 7]. The mean age of first clinical symptoms 
was 40 years. The mean time of Reynaud phenomenon was 
13.5 years, the minimum time from developing Raynaud 
phenomenon to the investigation was 3 years, the maxi-
mum 35 years.
At the time of investigation, the patients with lSSc were 
given vasodilators (pentoxifylline) and/or calcium channel 
antagonists and/or angiotensin receptor antagonists and 
vitamin E. Periodically, pentoxifylline and dextran infusions 
were administered. Patients with SSc also continued earlier 
instituted or modified, according to clinical indications, im-
munosuppressive treatment (low doses of corticosteroids 
— prednisone 0.5 mg/kg body mass/daily and/or metho-
trexate up to 15 mg/weekly).
Microcirculation in the investigated patients was as-
sessed with the use of the optical microscope OPTEK MC-
980. [objective: achromatic 4X/0.10; condencer 1/3”CMOS; 
resolution: 380 TVL (Television Lines), automatic white bal-
ance; video exit; 1Vp-p/75Ω.NTSC/PAL; power: 220V/110V; 
output: 9V; shifting table (size: 130  mm  × 118  mm; shift 
range: 64 mm × 28 mm]; light source: LED.
Layout and number of capillaries were assessed by ca-
pillaroscopic examination.
The study Nr. KE/3139/15 & RNN/218/09/KE was ap-
proved by Bioethical Committee, Medical University, Lodz.
Clinical data were transcribed to a Microsoft Office Excel 
spreadsheet and then analyzed statistically with the use 
of standard procedures. For statistical analysis STATISTICA 
v.10 was used. Differences and relationships p < 0.05 were 
considered statistically significant.
RESULTS
In capillaroscopic examination, the mean number of 
capillaries per 1 mm was 8.5 (min. 7/mm; max. 10/mm) in he-
althy individuals. A proper capillary loop resembled U letter 
and consisted of an ascending arm (arterial), ~10,45 µm in 
diameter and was narrower than a descending arm (venous), 
~12,76 µm in diameter. The ratio of an ascending arm width 
to descending one was smaller than 2:1 (Tab. 1). 
In SSc patients, the mean number of capillaries per 
1 mm was 4.28 (min.  1/mm; max.  10/mm), which was 
tissue diseases. Characteristic capillaroscopic pattern of 
capillary abnormalities is a good predictor in differentiating 
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Table 1. Assessment of morphology and distribution of capillaries in the investigated groups
Investigated groups
SSc  * lSSc  * dSSc  * control
Ascending limb  
of capillary loop
x 38.13 40.89 29.07 10.45
min. –max. 11–88 P < 0.05 11–88 P < 0.05 11–55 P < 0.05 7.7–11
SD 20.17 20.83 15.79 1.32
Descending limb  
of the capillary loop
x 39.97 42.57 31.43 12.76
min. –max. 11–110 P < 0.05 11–110 P < 0.05 11–55 P < 0.05 11–16.5
SD 21.52 22.08 18.44 2,75
Number of capillaries/mm x 4.28 4.18 4.57 8,50
min. –max. 1–10 P < 0.05 1–10 P < 0.05 2–6 P < 0.05 7–10
SD 1.67 1.76 1.40 1,04
x — mean; SD — standard deviation; *statistical significance p < 0.05 — mean; SD — standard deviation; *statistical significance p < 0.05
50% less than in the controls. A capillary loop consisted of 
an ascending limb ~38,13 µm (min. 11 µm; max. 88 µm) and 
was narrower than a descending- venous one ~39,97 µm 
(min. 11 µm; max. 110 µm). It was also found that size and 
density of capillary layout in SSc patients were statistically 
significantly different from the results obtained in healthy 
individuals (p < 0.05). No statistically significant difference 
in capillary size or density of layout was found between lSSc 
and dSSc (p > 0.05).
Pathological capillaries in SSc patients were statistically 
~3 fold wider than in the controls. Results of the statisti-
cal analysis showed avascular areas present in 53% of the 
patients with lSSc and 29% of dSSc patients; capillary he-
morrhage — 64% and 57%, respectively; megacapillaries 
— 41% and 29% ; lengthening of capillaries — 35% and 57%, 
bushy capillaries — 48% and 43%, respectively. However, 
the results of statistical analysis did not show relationship 
between the observed deviations in capillaroscopic picture 
and type of systemic sclerosis (lSSc vs dSSc) (p > 0.05).
DISCUSSION
At the end of the last century there was a great advance-
ment in understanding vascular disorders in the development 
of many diseases. As the microvasculopathy in the course of 
SSc are not fully understood, the research is being carried 
out. Capillaroscopic examination to assess blood vessels is 
considered an important element of diagnosing SSc patients 
[5, 6, 8] and also in monitoring the course of SSc [9, 10].
In the investigated group of SSc patients, deviations 
from the norm were found in all patients, however, there 
were no statistically significant differences between patients 
with lSSc and those with dSSc. The obtained data are in 
accordance with the subject literature, a characteristic capil-
laroscopic picture is observed in 85 to 100% patients [9,11] 
and depends on  duration of the disease, so proper vascular 
pattern in SSc patients by ACR and EULAR was not observed.
Rapid development of vascular disorders is observed 
mostly in the first years of the disease [5, 12]. Lovy et al. found 
relationship between duration of SSc and progressive vascu-
lar loss [13], which proves the need to monitor the disease 
with the use of capillaroscopy. Also layout of capillar size in 
the controls in capillaroscopic image was in accordance with 
that described by Michalska-Jakubus et al. [8].
No statistical significance was found between the ob-
served disorders such as vascular loss, mega-capillaries or 
capillary lengthening between lSSc patients and those with 
dSSc, which confirms an open question if lSSc and dSSc are 
separate diseases or phenotypes of the same disease.
Vascular disorders at the cellular scale may cause different 
organ changes in the course the disease [14, 15]. One of the 
first symptoms of SSc development is Reynaud’s phenome-
non. Secondary symptoms like skin and internal organ chan-
ges develop. Non-healing ulcers, pulmonary hypertension, 
coronary heart disease, disorders in respiratory, urinary and 
digestive systems appear. Interestingly, Sato et al. [16] found 
positive correlation between vascular loss, number of capil-
laries < 8/mm and involvement of more than three organs.
To sum up, the obtained data confirm significant diffe-
rences in between SSc patients and the healthy controls in 
capillaroscopic image. It must be stressed that monitoring 
of vascular changes may determine further organ diagnosis 
and treatment in the course of SSc but further studies are 
needed.
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